Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.89%
SPX
+0.96%
IXIC
+0.94%
FTSE
-0.19%
N225
+1.14%
AXJO
+0.95%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
324.40B
Dividend Yield
0.00%
P/E Ratio
77.33
EPS
2.41
Revenue
56.33B
Avg. Volume
7.55M

Recently from Cashu

publisher logo
Cashu

AbbVie: Amid Rising Drug Prices, Calls for Reform in U.S. Healthcare Intensify

1 day ago
publisher logo
Cashu

AbbVie’s Promising Study on Atogepant for Migraine Treatment Shows Significant Progress

3 days ago
publisher logo
Cashu

AbbVie Under Fire for Tax Practices Amid Legislative Push for Corporate Accountability

4 days ago

About

What does ABBV do?
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Illinois, USA
Website
http://www.abbvie.com
Stocks
Health Care
abbv
Abbvie
ABBV
-1.60 (-0.86%)
183.7
USD
At close at Jun 23, 20:33 UTC
Summary
News
Signals
Benchmarks
Financials